Similar articles for PMID: 12835716

Year	Number of Results
1994	1
1995	1
1998	1
1999	3
2000	6
2001	4
2002	12
2003	8
2004	5
2005	8
2006	11
2007	6
2008	11
2009	6
2010	4
2011	18
2012	14
2013	21
2014	7
2015	7
2016	16
2017	19
2018	15
2019	10
2020	12
2021	17
2022	14
2023	4
2024	0

1

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA. Chang F, et al. Leukemia. 2003 Jul;17(7):1263-93. doi: 10.1038/sj.leu.2402945. Leukemia. 2003. PMID: 12835716 Review.

2

Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.

Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moye PW, Franklin RA, Pohnert SC, Mirza AM, McMahon M, McCubrey JA. Shelton JG, et al. Oncogene. 2003 Apr 24;22(16):2478-92. doi: 10.1038/sj.onc.1206321. Oncogene. 2003. PMID: 12717425

3

Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.

Kogut MH, Genovese KJ, He H. Kogut MH, et al. Mol Immunol. 2007 Mar;44(7):1729-36. doi: 10.1016/j.molimm.2006.07.292. Epub 2006 Oct 12. Mol Immunol. 2007. PMID: 17045653

4

Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells.

McCubrey JA, Lee JT, Steelman LS, Blalock WL, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA, Pohnert SC. McCubrey JA, et al. Cancer Detect Prev. 2001;25(4):375-93. Cancer Detect Prev. 2001. PMID: 11531015

5

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA. McCubrey JA, et al. Biochim Biophys Acta. 2007 Aug;1773(8):1263-84. doi: 10.1016/j.bbamcr.2006.10.001. Epub 2006 Oct 7. Biochim Biophys Acta. 2007. PMID: 17126425 Free PMC article. Review.

6

Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.

Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V. Paumelle R, et al. Oncogene. 2002 Apr 4;21(15):2309-19. doi: 10.1038/sj.onc.1205297. Oncogene. 2002. PMID: 11948414

7

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M. McCubrey JA, et al. Adv Enzyme Regul. 2006;46:249-79. doi: 10.1016/j.advenzreg.2006.01.004. Epub 2006 Jul 18. Adv Enzyme Regul. 2006. PMID: 16854453

8

The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia.

Lee JT Jr, McCubrey JA. Lee JT Jr, et al. Leukemia. 2002 Apr;16(4):486-507. doi: 10.1038/sj.leu.2402460. Leukemia. 2002. PMID: 11960326 Review.

9

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Roberts PJ, Der CJ. Roberts PJ, et al. Oncogene. 2007 May 14;26(22):3291-310. doi: 10.1038/sj.onc.1210422. Oncogene. 2007. PMID: 17496923 Review.

10

Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.

Anders M, Christian C, McMahon M, McCormick F, Korn WM. Anders M, et al. Cancer Res. 2003 May 1;63(9):2088-95. Cancer Res. 2003. PMID: 12727824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

242 results

Results by year